Towards gene therapy for haemophilia B using primary human keratinocytes (Q45875232)

17 December 2017

title

Towards gene therapy for haemophilia B using primary human keratinocytes (English)

1 reference

17 December 2017

0 references

0 references

0 references

1 reference

4

1 reference

17 December 2017

author name string

Gerrard AJ

series ordinal

1

1 reference

17 December 2017

Hudson DL

series ordinal

2

1 reference

17 December 2017

Brownlee GG

series ordinal

3

1 reference

17 December 2017

language of work or name

English

0 references

publication date

1 February 1993

1 reference

17 December 2017

published in

Nature Genetics

1 reference

17 December 2017

volume

3

1 reference

17 December 2017

issue

2

1 reference

17 December 2017

page(s)

180-183

1 reference

17 December 2017

Redesign of retrovirus packaging cell lines to avoid recombination leading to helper virus production

cites work

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

An alternative approach to somatic cell gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Phenotypic correction of factor IX deficiency in skin fibroblasts of hemophilic dogs

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Expression of human factor IX in mice after injection of genetically modified myoblasts

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Expression of human factor IX in rat capillary endothelial cells: toward somatic gene therapy for hemophilia B

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Expression of human factor IX in rabbit hepatocytes by retrovirus-mediated gene transfer: potential for gene therapy of hemophilia B.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Prospects for epithelial gene therapy.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Expression of an exogenous growth hormone gene by transplantable human epidermal cells

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

The molecular basis of blood coagulation

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Cloning and Expression of the cDNA for Human γ-glutamyl Carboxylase

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

New techniques for the grafting of cultured human epidermal cells onto athymic animals

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Long-term transplantation of canine keratinocytes made resistant to G418 through retrovirus-mediated gene transfer

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Subcutaneous injection of factor IX for the treatment of haemophilia B

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Binding of factors IX and IXa to cultured vascular endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Regulation of factor IXa in vitro in human and mouse plasma and in vivo in the mouse. Role of the endothelium and the plasma proteinase inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

THE FATE OF PROTHROMBIN AND FACTORS VIII, IX AND X TRANSFUSED TO PATIENTS DEFICIENT IN THESE FACTORS.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Systemic distribution of apolipoprotein E secreted by grafts of epidermal keratinocytes: implications for epidermal function and gene therapy

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Serum proteins in human squamous epithelium

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Expression of active human clotting factor IX from recombinant DNA clones in mammalian cells

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

The gene structure of human anti-haemophilic factor IX.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Factors involved in production of helper virus-free retrovirus vectors.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Serial cultivation of strains of human epidermal keratinocytes: the formation of keratinizing colonies from single cells

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Monoclonal antibodies to factor IX: characterization and use in immunoassays for factor IX.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Immunoassays of factor IX antigen using monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Protein engineering of the propeptide of human factor IX

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Characteristics of a human diploid cell designated MRC-5.

1 reference

https://api.crossref.org/works/10.1038%2FNG0293-180

7 January 2021

Identifiers

DOI

10.1038/NG0293-180

1 reference

17 December 2017

Dimensions Publication ID

1027377728

0 references

1 reference

17 December 2017